This phase II study was performed to assess the feasibility of organ preservation after combined chemotherapy and radical radiation therapy in patients with resectable, locally advanced head and neck cancer.
Division of Radiation Oncology, Texas A&M University Health Science Center, College of Medicine, Scott and White Clinic and Memorial Hospital, Temple 76508, USA.
